Cellectar Biosciences, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -0.3459 | -100% |
| P/S |
|
0 | 33.76 | -100% |
|
|
| P/BV |
|
-23.25 | 4.82 | -582.34% |
|
|
| P/FCF |
|
0 | 61 | -100% |
|
|
| Ev/Ebitda |
|
-0.5809 | -22.15 | -97.38% |
|
|
| Ev/S |
|
0 | 22.56 | -100% |
|
|
| Ev/FCF |
|
-0.6775 | 68.78 | -100.99% |
|
|
| E/P |
|
0 | 0.0178 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 4.98 | -100% | -15107.12 | -100% |
| ROE |
|
2801.05 | 9.61 | 29042.4% |
|
|
| ROA |
|
-314.55 | 0.3443 | -91469.46% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
0 | -25.17 | -100% |
|
|
| ROCE |
|
2873.1 | 15.35 | 18616.88% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0143 | -3.68 | -99.61% | -0.0179 | -20.24% |
| Nеt Debt/Ebitda |
|
0.2325 | -3.44 | -106.76% |
|
|
| Debt/Ratio |
|
0.0458 | 0.1985 | -76.93% |
|
|
| Debt/Equity |
|
0 | 1.66 | -100% |
|
|
| Debt/Net Income |
|
-0.0146 | 10.32 | -100.14% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5442 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.2632 | -100% | ||
| DSI |
|
0 | 0.2193 | -100% |
|
|
| Average dividend growth |
|
0 | 0.4414 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4968 | -100% |
|
|
| Average percentage for payments |
|
243.91 | 43.56 | 459.87% |
|
|
| Difference from average difference in sector |
|
-0.5442 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-187.41 | -56.89 | 229.43% | ||
| Growth impulse Ebitda in 5 years |
|
173.02 | -54.68 | -416.42% | ||
| Growth impulse Net Income in 5 years |
|
173.26 | -58.33 | -397.03% | ||
| Growth impulse FCF in 5 years |
|
184.11 | -49.48 | -472.09% | ||
| Growth impulse EPS in 5 years |
|
-82.81 | -32.41 | 155.51% |
IP Score
4.48/10
